May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Long–Term Administration of Lipoic Acid Inhibits Retinopathy in Diabetic Rats via Regulating Mitochondrial Superoxide Dismutase
Author Affiliations & Notes
  • R.A. Kowluru
    Kresge Eye Inst Wayne St Univ, Detroit, MI
  • S. Odenbach
    Kresge Eye Inst Wayne St Univ, Detroit, MI
  • S. Basak
    Kresge Eye Inst Wayne St Univ, Detroit, MI
  • Footnotes
    Commercial Relationships  R.A. Kowluru, None; S. Odenbach, None; S. Basak, None.
  • Footnotes
    Support  EY014370, Juvenile Diabetes Research Foundation, Thomas Foundation, RPB
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 422. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.A. Kowluru, S. Odenbach, S. Basak; Long–Term Administration of Lipoic Acid Inhibits Retinopathy in Diabetic Rats via Regulating Mitochondrial Superoxide Dismutase . Invest. Ophthalmol. Vis. Sci. 2005;46(13):422.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Retinal mitochondria experience dysfunction in diabetes, and the therapies that inhibit superoxide production in the retina also inhibit the development of diabetic retinopathy. We have shown that long–term administration of lipoic acid has beneficial effects on the development of retinopathy in diabetic rats. The purpose of this study is to investigate the effect of administration of lipoic acid on the regulation of mitochondrial SOD (Mn–SOD) in the retina of diabetic rats. Methods: A group of streptozotocin diabetic rats received diet supplemented with or without α–lipoic acid (LA, 400mg/kg) for eleven months. The enzyme activity of SOD was measured using a kit from Cayman Chemical (Ann Arbor, MI) that utilizes tetrazolium salt to quantifying superoxide radicals. RNA was extracted by Trizol reagent, and reverse transcribed by the use of Sensiscript II Reverse transcriptase (Invitrogen, Carlsbad, CA). mRNA levels were quantified by real time RT–PCR using a Lightcycler from Roche Applied Science (Indianapolis, IN). Results: Mn–SOD activity was inhibited by over 30% in the retina of rats diabetic for eleven months, and its mRNA levels were reduced by 25% as compared with the values obtained from the age–matched normal rats. In the same diabetic animals, the number of apoptotic capillary cells and acellular capillaries was increased by 3–4 folds. LA administration for the entire duration of diabetes prevented diabetes–induced inhibition of retinal Mn–SOD activity and decrease in its mRNA levels. LA administration also inhibited increase in the number of apoptotic capillary cells and acellular capillaries in the retina of the same diabetic rats. Conclusions: Mitochondrial SOD is inhibited in the retina at duration of diabetes when retinopathy is developing; the therapy that inhibits retinal capillary cell apoptosis and histopathology in diabetic rats also prevents changes in retinal Mn–SOD. Thus, mitochondrial superoxides play an important role in the development of retinopathy in diabetes.

Keywords: diabetic retinopathy • antioxidants • mitochondria 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×